Helicore

NEWS

NextGen

BioSpace’s NextGen Class of 2026 Attracts Big Bucks From Tight Wallets

From biotech veterans to embattled modalities to a new wave of RNAi therapeutics, BioSpace’s NextGen Class of 2026 emerged during a tough fundraising environment in 2025. Check out the 15 battle-tested companies that caught our eye.

January 7, 2026

2 min read

Annalee Armstrong

IN THE PRESS

Press Releases

Helicore Biopharma Announces First Participant Dosed in Phase 1 Clinical Trial of HCR-188, a First-in-Class GIP Antagonist for the Treatment of Obesity

March 26, 2025

3 min read

Press Releases

Helicore Biopharma Emerges from Stealth to Continue Advancing Portfolio of First-in-Class GIP Antagonists for Obesity and Related Conditions

January 28, 2025

4 min read

Business

Helicor Announces Scientific Advisory Board

June 25, 2007

1 min read

AWARDS

JOBS